A Phase II Trial to Evaluate the Safety, Efficacy and Pharmacokinetics of Four Oral Doses of OPC-67683 in Patients With Uncomplicated, Smear-Positive, Pulmonary Tuberculosis
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2011
At a glance
- Drugs Delamanid (Primary) ; Rifampicin/isoniazid/pyrazinamide/ethambutol
- Indications Pulmonary tuberculosis
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 24 Sep 2010 New trial record.